Used as a key intermediate in the synthesis of rimonabant, a selective cannabinoid receptor antagonist. It plays a crucial role in pharmaceutical research targeting obesity and metabolic disorders. The compound's structure enables specific interactions with CB1 receptors, making it valuable in developing anti-obesity drugs and studying neurological pathways related to appetite regulation. It has also been explored in research on substance abuse and smoking cessation due to its effect on the central nervous system.